Health experts say the top diseases to watch for are measles, avian flu, filoviruses, Mpox, and insect-borne illnesses.

In Growing Biodefense Preparedness Efforts. Soligenix (NASDAQ: SNGX), a biopharmaceutical company focused on biodefense solutions, was featured in a recent article discussing its development of a vacc ...

Emerging and re-emerging infectious diseases can spread quickly. Experts say global travel, bugs and low vaccination rates ...

Find out more or buy tickets at aquarium.ucsd.edu. The La Jolla Music Society is starting a free “Music 101” lecture series ...

Researchers are edging closer to a universal antiviral drug, a single medicine that could treat every virus known to man.

An illustration of a self-assembling protein nanoparticle (SApNP) displaying Ebola virus surface proteins. This vaccine strategy is designed to help the immune system more effectively and respond to ...

Island Pharmaceuticals has secured a US patent for the use of Galidesivir to treat deadly filoviridae family viruses such as Marburg and Ebola. Patent Number 12,508,266 provides intellectual property ...

Investors like what they see from this drug company. The post Which biotech's shares are surging higher on US patent news? appeared first on The Motley Fool Australia.

Kawasaki disease (KD) has emerged as the most common cause of acquired heart disease in children in the developed world. The cause of KD remains unknown, although an as-yet unidentified infectious ...

Soligenix (NASDAQ: SNGX) is a New Jersey-based biopharmaceutical company focused on developing products to treat rare diseases where there is an unmet medical need. The company recently received ...